400 results
Keyword Citalopram Hexal Remove keyword
-
List item
Press release: EMA recommends aligning doses of metamizole medicines and their use during pregnancy and breastfeeding
CHMP, Last updated: 14/12/2018Freshalgin, Gardan, Generalgin, Hexalgin, Litalgin, Locamin, Metagelan … -
List item
National expert: Christine Greiner, Federal Institute for Drugs and Medical Devices (updated)
- Declaration of interests - 39.21 KB | PDF
- Curriculum Vitae - 30.87 KB | PDF
Haen E. Determination of citalopram and escitalopram together … -
List item
Referral: Sabumalin
salbutamol, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2008, EC decision date: 12/03/2009, Last updated: 30/03/2009Why was Sabumalin reviewed? Hexal AG submitted Sabumalin to … was Sabumalin reviewed? Hexal AG submitted Sabumalin to … concentration) Belgium Hexal AG Industriestr. 25 83607 … -
List item
Referral: Sanohex
salbutamol, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2008, EC decision date: 12/03/2009, Last updated: 30/03/2009Why was Sanohex reviewed? Hexal AG submitted Sanohex to the … Why was Sanohex reviewed? Hexal AG submitted Sanohex to the … Austria Hexal AG Industriestr. 25 83607 … -
List item
National expert: Anette Solli Karlsen, Norwegian Medicines Agency (updated)
- Declaration of interests - 39.36 KB | PDF
- Curriculum Vitae - 34.75 KB | PDF
quot;Simultaneous determination of citalopram, fluoxetine, paroxetine and … -
List item
Press release: European Medicines Agency: Committee for Medicinal Products for Human Use 24-27 July 2006
CHMP, Last updated: 28/07/2006Alendronat Hexal 10 mg … procedure for Alendronat Hexal 10 mg (alendronate), from Hexal A/S, Sweden, because of disagreements … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 February 2011
CHMP, Last updated: 18/02/2011Ibandronic Acid HEXAL … GmbH, and for Ibandronic Acid HEXAL (ibandronic acid), from Hexal AG, intended for the prevention … Sandoz and Ibandronic Acid HEXAL are generics of Bondronat … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP): 14-17 December 2009
CHMP, Last updated: 11/02/2010Temozolomide Hexal … opinions for Temozolomide Hexal (temozolomide), from Hexal AG, Temozolomide Sandoz … -
List item
Human medicine European public assessment report (EPAR): Rivastigmine Sandoz (updated)
rivastigmine, Dementia; Alzheimer Disease; Parkinson Disease
Date of authorisation: 10/12/2009, Revision: 14, Authorised, Last updated: 25/09/2023 -
List item
National expert: Nikica Mirošević Skvrce, Agency For Medicinal Products And Medical Devices Of Croatia (updated)
- Declaration of interests - 39.43 KB | PDF
- Curriculum Vitae - 25.79 KB | PDF
minimisation measures for (es)citalopram • Country: 1. Subject … -
List item
Human medicine European public assessment report (EPAR): Rivastigmine 1 A Pharma
rivastigmine, Alzheimer Disease; Dementia; Parkinson Disease
Date of authorisation: 11/12/2009, Revision: 15, Authorised, Last updated: 21/06/2023 -
List item
Press release: EMEA recommends a new warning for epoetins for their use in cancer patients
CHMP, Last updated: 26/06/2008Binocrit and Epoetin Alfa Hexal (epoetin alfa). Mircera (methoxy … Binocrit and Epoetin Alfa Hexal (epoetin alfa). Mircera … -
List item
Human medicine European public assessment report (EPAR): Diacomit
stiripentol, Myoclonic Epilepsy, Juvenile
Date of authorisation: 03/01/2007,
Date of refusal: 11/02/2009, Revision: 18, Authorised, Last updated: 25/08/2023 -
List item
Human medicine European public assessment report (EPAR): Lumeblue (previously known as Methylthioninium chloride Cosmo) (updated)
methylthioninium chloride, Colorectal Neoplasms; Colonoscopy
Date of authorisation: 19/08/2020, Revision: 3, Authorised, Last updated: 18/09/2023 -
List item
Human medicine European public assessment report (EPAR): Akynzeo (updated)
netupitant, palonosetron hydrochloride, Vomiting; Neoplasms; Nausea; Cancer
Date of authorisation: 27/05/2015, Revision: 16, Authorised, Last updated: 08/09/2023 -
List item
Human medicine European public assessment report (EPAR): Brilique
Ticagrelor, Peripheral Vascular Diseases; Acute Coronary Syndrome
Date of authorisation: 03/12/2010, Revision: 21, Authorised, Last updated: 03/08/2023 -
List item
Human medicine European public assessment report (EPAR): Orkambi
Lumacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 19/11/2015, Revision: 32, Authorised, Last updated: 27/07/2023 -
List item
Human medicine European public assessment report (EPAR): Azilect
rasagiline, Parkinson Disease
Date of authorisation: 21/02/2005, Revision: 23, Authorised, Last updated: 18/08/2023 -
List item
Human medicine European public assessment report (EPAR): Mysimba
bupropion hydrochloride, naltrexone hydrochloride, Obesity; Overweight
Date of authorisation: 26/03/2015,
, Revision: 25, Authorised, Last updated: 21/07/2023
-
List item
Human medicine European public assessment report (EPAR): Quviviq
daridorexant hydrochloride, Sleep Initiation and Maintenance Disorders
Date of authorisation: 29/04/2022,, Revision: 5, Authorised, Last updated: 23/06/2023
-
List item
Human medicine European public assessment report (EPAR): Buvidal
buprenorphine, Opioid-Related Disorders
Date of authorisation: 20/11/2018, Revision: 8, Authorised, Last updated: 16/08/2023 -
List item
Human medicine European public assessment report (EPAR): Hefiya (updated)
adalimumab, Spondylitis, Ankylosing; Hidradenitis Suppurativa; Psoriasis; Arthritis, Juvenile Rheumatoid; Uveitis
Date of authorisation: 26/07/2018,
, Revision: 14, Authorised, Last updated: 20/09/2023
-
List item
Human medicine European public assessment report (EPAR): Hyrimoz (updated)
adalimumab, Arthritis, Rheumatoid; Arthritis, Psoriatic; Spondylitis, Ankylosing; Uveitis; Hidradenitis Suppurativa; Colitis, Ulcerative; Arthritis, Juvenile Rheumatoid; Crohn Disease; Skin Diseases, Papulosquamous
Date of authorisation: 26/07/2018,, Revision: 13, Authorised, Last updated: 20/09/2023
-
List item
Human medicine European public assessment report (EPAR): Nexium Control
esomeprazole, Gastroesophageal Reflux
Date of authorisation: 26/08/2013, Revision: 17, Authorised, Last updated: 24/04/2023 -
List item
Human medicine European public assessment report (EPAR): Rivastigmine Actavis
rivastigmine hydrogen tartrate, Dementia; Alzheimer Disease; Parkinson Disease
Date of authorisation: 16/06/2011,
, Revision: 17, Authorised, Last updated: 05/07/2023